Clinical Scorecard: Early PPV With ILM Peeling Shows Durable Outcomes in Selected DME Patients
At a Glance
| Category | Detail |
|---|---|
| Condition | Diabetic Macular Edema (DME) |
| Key Mechanisms | Early pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling |
| Target Population | Treatment-naïve DME patients unwilling or unable to adhere to anti-VEGF treatment schedules |
| Care Setting | Multicenter surgical intervention |
Key Highlights
- Significant improvements in visual acuity and retinal thickness observed at 24 months post-surgery
- Mean best-corrected visual acuity improved from 0.66 logMAR to 0.53 logMAR
- 43% of patients gained at least five ETDRS letters; 31.7% gained 10 or more letters
- Earlier surgery associated with better visual outcomes; each day of delay decreased chances of improvement by 1.8%
- Safety profile consistent with expectations for vitrectomy; cataract progression noted in phakic patients
Guideline-Based Recommendations
Diagnosis
- Identify treatment-naïve patients with DME for surgical consideration
Management
- Consider early PPV with ILM peeling for patients unable to adhere to anti-VEGF therapy
Monitoring & Follow-up
- Follow-up for visual acuity and retinal thickness at regular intervals post-surgery
Risks
- Potential cataract progression and need for IOP-lowering medications in some patients
Patient & Prescribing Data
120 treatment-naïve DME patients undergoing PPV with ILM peeling
No supplemental anti-VEGF therapy required during 24-month follow-up
Clinical Best Practices
- Select patients with favorable OCT biomarkers for surgery
- Prioritize early intervention to maximize visual outcomes
- Monitor for cataract progression and manage IOP as needed
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.